Oncology & Cancer

HIV drug may slow down metastatic breast cancer

The HIV drugs known as CCR5 antagonists may also help prevent aggressive breast cancers from metastasizing, researchers from the Kimmel Cancer Center at Jefferson suggest in a preclinical study published in a recent issue ...

Oncology & Cancer

New target, new drug in breast cancer

Many breast cancers depend on hormones including estrogen or progesterone for their survival and proliferation. Eight years of lab work at the University of Colorado Cancer Center and elsewhere suggest that the androgen (AR) ...

Oncology & Cancer

Vitamin D influences racial differences in breast cancer risk

American women of African ancestry are more likely than European Americans to have estrogen receptor (ER) negative breast cancer. There continues to be discussion about the role of low levels of vitamin D in the development ...

Medical research

Estrogen is responsible for slow wound healing in women

Estrogen causes wounds in women to heal slower than in men - who have lower levels of estrogen - says a new study published in the April 2012 issue of the FASEB Journal. In the report, scientists from the University of California, ...

Oncology & Cancer

PI3K/mTOR pathway proteins tied to poor prognosis in breast cancer

Four proteins involved in translation, the final step of general protein production, are associated with poor prognosis in hormone-receptor-positive breast cancer when they are dysregulated, researchers reported at the AACR ...

page 23 from 30